Human cytomegalovirus vaccine development: Immune responses to look into vaccine strategy

Human cytomegalovirus vaccine development: Immune responses to look into vaccine strategy

Human cytomegalovirus (HCMV) causes considerable morbidity and disability in high risk, immunocompromised populations including recipients of solid organ transplants, and fetuses whose immune systems are not yet mature. Vaccines aimed at ameliorating the severity of disease and preventing HCMV infec...

Full description

Bibliographic Details
Main Authors: Lin Xia, Ruopeng Su, Zhiqiang An, Tong-Ming Fu, Wenxin Luo
Format: Article
Language:English
Published: Taylor & Francis Group 2018-02-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
human cytomegalovirus
vaccine
immune response
neutralizing antibodies
t cells
Online Access:http://dx.doi.org/10.1080/21645515.2017.1391433

Internet

http://dx.doi.org/10.1080/21645515.2017.1391433

Similar Items